170033-55-3 Usage
Uses
Used in Pharmaceutical Synthesis:
(R)-3-Methyl-1-(phenylmethyl)piperazin-2-one is used as a building block for the synthesis of other pharmaceuticals and organic compounds, leveraging its structural properties to create a diverse array of molecules with potential therapeutic applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (R)-3-Methyl-1-(phenylmethyl)piperazin-2-one is used as a modulator of neurotransmitter systems in the central nervous system, which can be crucial for the development of treatments targeting neurological and psychiatric disorders.
Used in Neurology and Psychiatry:
(R)-3-Methyl-1-(phenylmethyl)piperazin-2-one is employed as a potential therapeutic agent for the treatment of various neurological and psychiatric disorders, due to its ability to interact with and modulate neurotransmitter systems in the brain.
Used in Drug Development:
(R)-3-Methyl-1-(phenylmethyl)piperazin-2-one is utilized in drug development as a starting point for the creation of novel compounds with specific therapeutic targets, potentially leading to the discovery of new medications for a variety of conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 170033-55-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,0,0,3 and 3 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 170033-55:
(8*1)+(7*7)+(6*0)+(5*0)+(4*3)+(3*3)+(2*5)+(1*5)=93
93 % 10 = 3
So 170033-55-3 is a valid CAS Registry Number.
170033-55-3Relevant academic research and scientific papers
Asymmetric Synthesis of 2,6-Methylated Piperazines
Mickelson, John W.,Belonga, Kenneth L.,Jacobsen, Jon E.
, p. 4177 - 4183 (2007/10/02)
The complete series of enantiopure 2,6-methylated piperazines was synthesized utilizing two alternative reactions in the key bond-forming step.The dimethyl enantiomers, (2R,6R)- and (2S,6S)-2,6-dimethylpiperazine (1, 2), were prepared using either a diastereoselective triflate alkylation or a novel intermolecular Mitsunobu reaction to set the required stereochemistry.The monomethyl derivatives, (R)- and (S)-tert-butyl 2-methyl-1-piperazinecarboxylate (3, 4) were also synthesized employing the Mitsunobu cyclization strategy while the trimethyl compounds, (R)- and (S)-2,2,6- trimethylpiperazine (5, 6) were prepared using an enantiospecific triflate alkylation as the principal reaction.These methods represent efficient, general strategies for preparing a variety of 2,6-methylated piperazines for which the absolute stereochemistry can be readily controlled.
